Sinopharm Group Overview

  • Status
  • Public
  • Employees
  • 113,234
Employees
  • Stock Symbol
  • 01099
Stock Symbol
  • Investments
  • 7
  • Share Price
  • $2.35
  • (As of Wednesday Closing)

Sinopharm Group General Information

Description

Sinopharm Group was founded in 2003 and listed on the Hong Kong Stock Exchange in September 2009. Its main business is drug distribution in mainland China, which contributes about 76% of total revenue. It is the largest drug distributor, with approximately 20% market share. Other notable segments are medical device distribution, which contributes about 20% of revenue, and retail pharmacies, which contributes about 5%. These are fast-growing industries, where government policy is designed to encourage consolidation and promote large players with scale and efficiency advantages.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
HKG
Primary Office
  • Sinopharm Plaza
  • No. 1001 Zhongshan Road (West), Changning District
  • Shanghai, 200051
  • China
+86 00000000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sinopharm Group Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.35 $2.36 $2.08 - $3.61 $7.35B 3.12B 4.75M $0.39

Sinopharm Group Financials Summary

In Thousands,
USD
TTM 31-Dec-2021 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 20,370,077 20,370,077 18,439,816 20,700,770
Revenue 80,694,561 80,694,561 66,064,608 61,547,740
EBITDA 3,735,976 3,735,976 3,176,270 2,865,121
Net Income 1,201,572 1,201,572 1,040,336 904,901
Total Assets 52,621,126 52,621,126 47,638,514 38,573,115
Total Debt 10,725,945 10,725,945 10,488,854 7,880,639
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sinopharm Group Executive Team (2)

Name Title Board Seat Contact Info
Yong Liu Board Member & President
Xiaojuan Li Chief Financial Officer
To view Sinopharm Group’s complete executive team members history, request access »

Sinopharm Group Board Members (15)

Name Representing Role Since
000000 000 Sinopharm Group Board Member 000 0000
0000000 0000 00.0 Sinopharm Group Board Member 000 0000
00000 0000 Self Board Member 000 0000
0000000 00 Sinopharm Group Board Member 000 0000
0000000 0000 Sinopharm Group Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

Sinopharm Group Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sinopharm Group Investments & Acquisitions (7)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000-000 000 28-Mar-2021 00000 0000 Pharmaceuticals 000 00000
00 0000000 16-Nov-2020 00000 0000 0000 Decision/Risk Analysis
0000000000000 01-May-2019 00000 0000 000.00 Discovery Tools (Healthcare)
00000 0000000 20-Jul-2016 0000000000 00000 Pharmaceuticals 000000 00
Sinopharm Holding Medical Investment Management 17-Sep-2015 Secondary Transaction - Private 000.00 Other Healthcare 000000 00
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Sinopharm Group Subsidiaries (3)

Company Name Industry Location Founded
China National Medicines Corporation Pharmaceuticals Beijing, China 1999
00000 00000000 000 PE/Buyout Beijing, China
000000000 0000000 Venture Capital Shanghai, China
To view Sinopharm Group’s complete subsidiaries history, request access »

Sinopharm Group Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000000000 01-May-2019 00000 00000 00 000.00 Completed
  • 2 buyers
To view Sinopharm Group’s complete exits history, request access »